Ga-68 FAPI-04 PET/CT detection of repeatedly biopsy-negative poorly differentiated gastric adenocarcinoma: a case report - Scorecard - MDSpire

Detection of Poorly Differentiated Gastric Adenocarcinoma Using Ga-68 FAPI-04 PET/CT in a Case with Repeatedly Negative Biopsies

  • By

  • Zhipeng Cheng

  • Xiuxiu Chang

  • Yuying Lei

  • Na Liu

  • Jing Wu

  • Lifei Zhang

  • Aixia Sui

  • July 17, 2026

Share

Clinical Scorecard: Detection of Poorly Differentiated Gastric Adenocarcinoma Using Ga-68 FAPI-04 PET/CT in a Case with Repeatedly Negative Biopsies

At a Glance

CategoryDetail
ConditionPoorly Differentiated Gastric Adenocarcinoma
Key MechanismsGa-68 FAPI PET/CT targets fibroblast activation protein expressed by cancer-associated fibroblasts, enhancing tumor-to-background contrast.
Target PopulationPatients with suspected infiltrative gastric cancer and negative biopsy results.
Care SettingMultidisciplinary diagnostic-therapeutic planning in a hospital setting.

Key Highlights

  • False-negative endoscopic biopsies can delay diagnosis of infiltrative gastric cancer.
  • Ga-68 FAPI-04 PET/CT showed clearer lesion delineation compared to F-18 FDG PET/CT.
  • Distal gastrectomy was performed for symptom relief and definitive diagnosis.
  • Final histopathology confirmed poorly differentiated gastric adenocarcinoma with partial signet-ring cell morphology.
  • Postoperative treatment included XELOX chemotherapy.

Guideline-Based Recommendations

Diagnosis

  • Consider Ga-68 FAPI-04 PET/CT when repeated endoscopic biopsies are non-diagnostic but suspicion for malignancy persists.

Management

  • Distal gastrectomy may be indicated for symptom relief and definitive diagnosis in cases of suspected gastric cancer.

Monitoring & Follow-up

  • Follow-up for clinical stability and response to postoperative chemotherapy.

Risks

  • Potential for delayed diagnosis due to false-negative biopsy results.

Patient & Prescribing Data

Adult patients with suspected gastric cancer and negative biopsy results.

Postoperative XELOX chemotherapy is a treatment option following diagnosis.

Clinical Best Practices

  • Utilize multidisciplinary consultations in complex diagnostic cases.
  • Consider advanced imaging techniques like Ga-68 FAPI-04 PET/CT for improved diagnostic accuracy.

Related Resources & Content

    Original Source(s)

    Related Content